Find the available answers about tranylcypromine and supplements. Each guide explains its evidence and the forms it covers.
10 published guides. Coverage is limited to the combinations listed.
Oral Hypericum perforatum preparations used for mood symptoms with oral MAOI treatment. Other botanical species, topical preparations and specific extract strengths are not assumed to be equivalent.
Read the interaction guide →Oral L-tyrosine supplements with tranylcypromine tablets. Tyrosine is not tyramine, and neither ordinary protein foods nor other amino acids are automatically included.
Read the interaction guide →Oral L-5-hydroxytryptophan with oral tranylcypromine tablets. This does not identify a safe amount, equate 5-HTP with L-tryptophan, or clear a mixed botanical product.
Read the interaction guide →Oral Paullinia cupana seed preparations that contain caffeine. No assumption is made about the caffeine concentration of an unidentified brand, a different plant part or a caffeine-free preparation.
Read the interaction guide →Oral tranylcypromine tablets with caffeine from drinks, tablets, powders or other supplements. The concern depends on total exposure; no universal safe amount has been established for this combination.
Read the interaction guide →Oral Ephedra sinica stem or above-ground preparations containing ephedrine-type alkaloids. The assessment does not equate root preparations, other species, purified ephedrine products or unverified alkaloid-free products.
Read the interaction guide →Oral supplemental S-adenosyl-L-methionine, commonly called SAM-e, with oral tranylcypromine. Different commercial salts and blends are not assumed to have identical exposure, and no safe product-specific dose is established.
Read the interaction guide →Oral supplemental L-tryptophan with oral tranylcypromine. The multiagent case includes clomipramine and is not treated as a clean two-agent experiment; normal dietary protein is a separate question.
Read the interaction guide →Camellia sinensis, particularly oral leaf beverages or preparations containing caffeine. This species-level selection does not identify a particular extract, caffeine content or topical formulation.
Read the interaction guide →Oral Herba Ephedrae products consisting of ephedra herb with ephedrine-type alkaloids. The canonical node is kept separate from Ephedra sinica; species, plant part and alkaloid content remain product-specific.
Read the interaction guide →A supplement missing from this list has not been cleared for use with the medication. These pages do not assess every product, formulation, or combination.
Publication status, clinical review and change history are shown in each interaction guide.